Maturity-onset diabetes of the young (MODY) as a result of mutations in hepatocyte nuclear factor 1-α (HNF1A) is often misdiagnosed as type 1 diabetes or type 2 diabetes. Recent work has shown that high-sensitivity C-reactive protein (hs-CRP) levels are lower in HNF1A-MODY than type 1 diabetes, type 2 diabetes, or glucokinase (GCK)-MODY. We aim to replicate these findings in larger numbers and other MODY subtypes.RD&E staff can access the full-text of this article via OpenAthens. Click on the 'Additional Link' above to access the full-text and log in with NHS OpenAthens if prompted.DHCS/07/07/008/Department of Health/United Kingdom G0700222/Medical Research Council/United Kingdom G0700222(81696)/Medical Research Council/United Kingdo
Maturity-onset diabetes of the young (MODY) is a monogenic disorder characterized by autosomal domin...
Published as an e-pub ahead of print 8th June 2015.Maturity onset diabetes of the young (MODY) is a ...
Objective. To characterize initial presentation and clinical course of patients with hepatocyte nucl...
Maturity-onset diabetes of the young (MODY) as a result of mutations in hepatocyte nuclear factor 1-...
We have read with great interestthe article recently published byMcDonald et al. (1) replicating the...
An accurate molecular diagnosis of diabetes subtype confers clinical benefits; however, many individ...
AIMS/HYPOTHESIS: An accurate molecular diagnosis of diabetes subtype confers clinical benefits; howe...
OBJECTIVE: Despite the clinical importance of an accurate diagnosis in individuals with monogenic fo...
Maturity-onset diabetes of the young (MODY), due to hepatocyte nuclear factor 1 alpha mutations (HNF...
The authors report an adolescent who was found to have diabetes on routine blood testing. The initia...
Background: Young adults with diabetes in Asia represent a heterogeneous group. Using traditional cl...
HNF1A-MODY is the most common form of monogenic diabetes, but due to low awareness among clinicians ...
OBJECTIVE Maturity-onset diabetes of the young (MODY) due to variants in HNF1A is the commonest type...
ObjectiveMaturity-onset diabetes of the young caused by hepatocyte nuclear factor-1 alpha (HNF1A) va...
Assigning the correct aetiology in diabetes is important for treatment, understanding prognosis and ...
Maturity-onset diabetes of the young (MODY) is a monogenic disorder characterized by autosomal domin...
Published as an e-pub ahead of print 8th June 2015.Maturity onset diabetes of the young (MODY) is a ...
Objective. To characterize initial presentation and clinical course of patients with hepatocyte nucl...
Maturity-onset diabetes of the young (MODY) as a result of mutations in hepatocyte nuclear factor 1-...
We have read with great interestthe article recently published byMcDonald et al. (1) replicating the...
An accurate molecular diagnosis of diabetes subtype confers clinical benefits; however, many individ...
AIMS/HYPOTHESIS: An accurate molecular diagnosis of diabetes subtype confers clinical benefits; howe...
OBJECTIVE: Despite the clinical importance of an accurate diagnosis in individuals with monogenic fo...
Maturity-onset diabetes of the young (MODY), due to hepatocyte nuclear factor 1 alpha mutations (HNF...
The authors report an adolescent who was found to have diabetes on routine blood testing. The initia...
Background: Young adults with diabetes in Asia represent a heterogeneous group. Using traditional cl...
HNF1A-MODY is the most common form of monogenic diabetes, but due to low awareness among clinicians ...
OBJECTIVE Maturity-onset diabetes of the young (MODY) due to variants in HNF1A is the commonest type...
ObjectiveMaturity-onset diabetes of the young caused by hepatocyte nuclear factor-1 alpha (HNF1A) va...
Assigning the correct aetiology in diabetes is important for treatment, understanding prognosis and ...
Maturity-onset diabetes of the young (MODY) is a monogenic disorder characterized by autosomal domin...
Published as an e-pub ahead of print 8th June 2015.Maturity onset diabetes of the young (MODY) is a ...
Objective. To characterize initial presentation and clinical course of patients with hepatocyte nucl...